Aerwave Medical develops an alternative to traditional medications used to treat COPD and asthma.
Aerwave Medical has raised $12.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Aerwave Medical's investors include Lucius Partners.
Aerwave Medical is headquartered in New York, United States.
Aerwave Medical develops an alternative to traditional medications used to treat COPD and asthma.
Aerwave Medical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aerwave Medical — Funding & Investors." VCBacked, January 8, 2025, https://www.vcbacked.co/company/aerwave-medical. Accessed September 30, 2026.
VCBacked. (2025). Aerwave Medical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/aerwave-medical
{{cite web |title=Aerwave Medical — Funding & Investors |url=https://www.vcbacked.co/company/aerwave-medical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated